http://mobile.reuters.com/article/idUSKBN1722XB [reuters.com]
A recall for epipens will now extend to asia, europe, north, and south America:
Generic drugmaker Mylan NV said on Friday that its manufacturing partner for EpiPen devices had expanded a recall of the life-saving allergy shot in the United States and other markets.
The announcement comes a week after Mylan said it had recalled about 81,000 EpiPen devices in countries outside the United States following two reports of the company's allergy treatment failing to work in emergencies.